{"id":1063172,"date":"2012-07-22T15:47:57","date_gmt":"2012-07-22T15:47:57","guid":{"rendered":"http:\/\/www.longevitymedicine.tv\/uc-davis-researchers-score-big-in-113-million-stem-cell-award-round\/"},"modified":"2024-08-17T20:27:34","modified_gmt":"2024-08-18T00:27:34","slug":"uc-davis-researchers-score-big-in-113-million-stem-cell-award-round-2","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/stem-cell-therapy\/uc-davis-researchers-score-big-in-113-million-stem-cell-award-round-2.php","title":{"rendered":"UC Davis Researchers Score Big in $113 Million Stem Cell Award Round"},"content":{"rendered":"

<\/a>
<\/a><\/p>

Scientists at the <\/span>University of
California at Davis<\/b> are set to win nearly half of $113 million
expected to be awarded next week by the California stem cell agency
as it pushes aggressively to turn research into marketplace cures.<\/span><\/p>

<\/div>
Directors of the $3 billion agency are
virtually certain to approve awards to three researchers at UC Davis,
which operates its medical school and other research facilities in
nearby Sacramento. The other three expected winners are from UCLA,
Stanford <\/b>and StemCells, Inc<\/b>., of Newark, Ca., a publicly traded firm.<\/div>
<\/div>
The $113 million round is the second largest research round<\/a> in CIRM<\/b>'s history, surpassed only by an
another, earlier $211 million “disease team” round. The latest
effort is aimed at bringing proposed clinical trials to the FDA for approval or possibly starting trials within four years.<\/a> That deadline
is close to the time when CIRM is scheduled to run out of cash unless
new funding sources are developed.<\/div>
<\/div>
CIRM is currently exploring seeking
private financing. It could also ask voters to approve another state
bond issue. (Bonds currently provide the only real source of cash for
CIRM.)  In either case, the agency needs strong, positive results from
its grantees to support a bid for continued funding.<\/div>
<\/div>
The CIRM board is scheduled to approve
the latest awards one week from tomorrow at a public meeting in Burlingame<\/a> in the San Francisco area. The agency's policy is to
withhold the identities of applicants and winners until after formal
board action. The California Stem Cell Report<\/b>, however, has pieced
together their identities from public records.<\/div>
<\/div>
Here are the winners and links to the
grant review summaries, listed in order of the CIRM scientific
scores:<\/div>
<\/div>